Inhibition of the Wnt pathway by the secreted
glycoprotein, Dickkopf-1 (Dkk-1) has been related to processes of excitotoxic and ischemic neuronal death. We now report that Dkk-1 is induced in neurons of the rat olfactory cortex and hippocampus degenerating in response to
seizures produced by systemic injection of
kainate (12 mg/kg, i.p.). There was a tight correlation between Dkk-1 expression and neuronal death in both regions, as shown by the different expression profiles in animals classified as "high" and "low" responders to
kainate. For example, no induction of Dkk-1 was detected in the hippocampus of low responder rats, in which
seizures did not cause neuronal loss. Induction of Dkk-1 always anticipated neuronal death and was associated with a reduction in nuclear levels of
beta-catenin, which reflects an ongoing inhibition of the canonical Wnt pathway. Intracerebroventricular
injections of Dkk-1
antisense oligonucleotides (12 nmol/2 microL) substantially reduced
kainate-induced neuronal damage, as did a pretreatment with
lithium ions (1 mEq/kg, i.p.), which rescue the Wnt pathway by acting downstream of the Dkk-1 blockade. Taken collectively, these data suggest that an early inhibition of the Wnt pathway by Dkk-1 contributes to neuronal damage associated with
temporal lobe epilepsy. We also examined Dkk-1 expression in the hippocampus of epileptic patients and their controls. A strong Dkk-1 immunolabeling was found in six bioptic samples and in one autoptic sample from patients with mesial
temporal lobe epilepsy associated with
hippocampal sclerosis. Dkk-1 expression was undetectable or very low in autoptic samples from nonepileptic patients or in bioptic samples from patients with
complex partial seizures without neuronal loss and/or reactive
gliosis in the hippocampus. Our data raise the attractive possibility that drugs able to rescue the canonical Wnt pathway, such as Dkk-1 antagonists or inhibitors of
glycogen synthase kinase-3beta, reduce the development of
hippocampal sclerosis in patients with
temporal lobe epilepsy.